http://whqlibdoc.who.int/hq/1998/WHO_DMP_RGS_98.5.pdf

It provides guidance to countries which do not already have a fully functioning system of premarket evaluation and market authorization, and have a particular interest in the assessment and authorization of multisource (generic) pharmaceutical products.